Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction

NCT06619600 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)
Diabetes Mellitus
Heart Failure
Myocardial Fibrosis

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

Hospital Clinic of Barcelona